Get the Stockscreener App
30.34
1.30%
0.39
After Hours:
30.34
Veracyte Inc stock is traded at $30.34, with a volume of 814.30K.
It is up +1.30% in the last 24 hours and up +23.99% over the past month.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
See More
Previous Close:
$29.95
Open:
$30.07
24h Volume:
814.30K
Relative Volume:
0.58
Market Cap:
$2.39B
Revenue:
$399.58M
Net Income/Loss:
$-54.04M
P/E Ratio:
-40.45
EPS:
-0.75
Net Cash Flow:
$40.13M
1W Performance:
-2.13%
1M Performance:
+23.99%
6M Performance:
-10.34%
1Y Performance:
-5.01%
1-Day Range:
$29.79
$30.69
1-Week Range:
$28.25
$30.69
52-Week Range:
$22.61
$47.32
Veracyte Inc Stock (VCYT) Company Profile
Name
Veracyte Inc
Sector
Industry
Phone
(650) 243-6300
Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
30.34 | 2.36B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
492.72 | 184.93B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.82 | 147.00B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
647.09 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.66 | 35.50B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.81 | 32.08B | 15.70B | 1.24B | 2.01B | 6.91 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-20-25 | Initiated | Craig Hallum | Buy |
| Dec-05-24 | Downgrade | Goldman | Buy → Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Oct-16-24 | Initiated | UBS | Buy |
| Oct-10-24 | Initiated | Guggenheim | Buy |
| Feb-23-24 | Reiterated | Needham | Buy |
| Jan-18-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-07-22 | Initiated | Stephens | Overweight |
| Nov-18-21 | Resumed | Goldman | Buy |
| Jun-15-21 | Initiated | Raymond James | Outperform |
| Feb-18-21 | Resumed | Needham | Buy |
| Jan-28-21 | Initiated | Truist | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-09-20 | Initiated | Morgan Stanley | Underweight |
| Jul-31-19 | Initiated | Lake Street | Buy |
| Jul-02-19 | Initiated | Needham | Buy |
| Nov-29-18 | Downgrade | Janney | Buy → Neutral |
| Oct-31-18 | Upgrade | Janney | Neutral → Buy |
| Nov-07-17 | Downgrade | Janney | Buy → Neutral |
| Nov-07-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-31-17 | Resumed | BTIG Research | Buy |
| Nov-14-16 | Resumed | Leerink Partners | Outperform |
| Dec-18-15 | Initiated | Cantor Fitzgerald | Buy |
| Jun-11-15 | Reiterated | Leerink Partners | Outperform |
| Nov-26-13 | Initiated | William Blair | Outperform |
View All
Veracyte Inc Stock (VCYT) Latest News
Is this a good reentry point in Veracyte IncMarket Sentiment Review & Long-Term Capital Growth Strategies - Newser
Is this a good reentry point in Veracyte Inc.Watch List & Verified Momentum Stock Alerts - Newser
Why Veracyte Inc. is moving todayMarket Sentiment Report & AI Forecast Swing Trade Picks - Newser
Using data filters to optimize entry into Veracyte Inc.Bear Alert & Safe Capital Growth Tips - Newser
Can Veracyte Inc. hit a new high this monthTrade Ideas & Fast Moving Market Watchlists - Newser
Analyzing drawdowns of Veracyte Inc. with statistical toolsMarket Growth Summary & High Conviction Buy Zone Alerts - Newser
Live market analysis of Veracyte Inc.Rate Hike & Community Verified Trade Signals - Newser
Real time breakdown of Veracyte Inc. stock performancePortfolio Return Report & Free Reliable Trade Execution Plans - Newser
Veracyte Inc. Building a Base Near Support getLinesFromResByArray error: size == 0 - thegnnews.com
Veracyte Inc. Shows Early Signs of Technical Strength getLinesFromResByArray error: size == 0 - kangso.co.kr
Real time alert setup for Veracyte Inc. performanceEarnings Risk Summary & High Accuracy Trade Signal Alerts - Newser
Measuring Veracyte Inc.’s beta against major indices2025 Price Action Summary & AI Driven Price Forecasts - Newser
Veracyte Inc.’s volatility index tracking explainedTrade Analysis Report & Verified Stock Trade Ideas - Newser
Developing predictive dashboards with Veracyte Inc. dataExit Point & High Accuracy Buy Signal Tips - Newser
Applying big data sentiment scoring on Veracyte Inc.Portfolio Growth Summary & AI Driven Stock Reports - Newser
RSI Crosses Above 30 for Veracyte Inc. — Reversal in SightInflation Watch & Fast Moving Stock Watchlists - beatles.ru
Understanding Veracyte Inc.’s price movementGap Down & Weekly Setup with High ROI Potential - Newser
Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking After Shares Rocket 27% - simplywall.st
Is now a turning point for Veracyte Inc.Quarterly Market Summary & Precise Trade Entry Recommendations - Newser
Veracyte’s Strategic Position in the Evolving Precision Oncology Landscape - AInvest
What machine learning models say about Veracyte Inc.2025 Breakouts & Breakdowns & Consistent Profit Alerts - Newser
Is it time to cut losses on Veracyte Inc.2025 Bull vs Bear & Expert-Curated Trade Recommendations - Newser
Can Veracyte Inc. recover in the next quarter2025 Major Catalysts & Pattern Based Trade Signal System - Newser
Applying Elliott Wave Theory to Veracyte Inc.July 2025 EndofMonth & Fast Entry High Yield Stock Tips - Newser
How institutional ownership impacts Veracyte Inc. stockQuarterly Earnings Summary & Long-Term Capital Growth Strategies - Newser
Momentum divergence signals in Veracyte Inc. chartInsider Selling & Free Verified High Yield Trade Plans - Newser
Is Veracyte Inc. stock ready for a breakout2025 Valuation Update & Fast Moving Stock Trade Plans - Newser
Forecasting Veracyte Inc. price range with options dataMarket Sentiment Review & Risk Controlled Daily Trade Plans - Newser
Candlestick Reversal Detected on Veracyte Inc.’s Chart getLinesFromResByArray error: size == 0 - 클래시안
Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today - Yahoo Finance
Veracyte to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - Business Wire
Veracyte Inc Stock (VCYT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Veracyte Inc Stock (VCYT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bhanji Muna | Director |
Jun 13 '25 |
Sale |
26.67 |
4,589 |
122,367 |
29,989 |
1.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):